SENS PubMed Publication Search
Glomerular endothelial cell senescence drives age-related kidney disease through PAI-1
EMBO Mol Med. 2021 Nov 2;e14146. doi: 10.15252/emmm.202114146.
Camille Cohen 1, Océane Le Goff 1, Frédéric Soysouvanh 2, Florence Vasseur 1, Marine Tanou 1, Clément Nguyen 1, Lucile Amrouche 1 3, Julien Le Guen 4, Oriana Saltel-Fulero 4, Tanguy Meunier 4, Thao Nguyen-Khoa 1 5, Marion Rabant 1 6, Dominique Nochy 7, Christophe Legendre 1 3, Gérard Friedlander 1, Bennett G Childs 8, Daren J Baker 8 9, Bertrand Knebelmann 1 3, Dany Anglicheau 1 3, Fabien Milliat 2, Fabiola Terzi 1
Abstract:
...Here, we uncovered an unexpected role for glomerular endothelial cells during aging. In fact, we discovered a detrimental cross-talk between senescent endothelial cells and podocytes, through PAI-1. In vivo, selective inactivation of PAI-1 in endothelial cells protected glomeruli from lesion development and podocyte loss in aged mice. In vitro, blocking PAI-1 in supernatants from senescent endothelial cells prevented podocyte apoptosis. Consistently, depletion of senescent cells prevented podocyte loss in old p16 INK-ATTAC transgenic mice. Importantly, these experimental findings are relevant to humans. We showed that glomerular PAI-1 expression was predictive of poor outcomes in transplanted kidneys from elderly donors. In addition, we observed that in elderly patients, urinary PAI-1 was associated with age-related chronic kidney disease. Altogether, these results uncover a novel mechanism of kidney disease and identify PAI-1 as a promising biomarker of kidney dysfunction in allografts from elderly donors.
PMID: 34725920
Free Full-Text: https://www.embopress.org/doi/full/10.15252/emmm.202114146
Tags: Kidney disease, mice, PAI-1, senolytics